82 related articles for article (PubMed ID: 16306197)
1. Increased NCAM expression and vascular development in trisomy 16 mouse embryos: relationship with nuchal translucency.
Bekker MN; Arkesteijn JB; van den Akker NM; Hoffman S; Webb S; van Vugt JM; Gittenberger-de Groot AC
Pediatr Res; 2005 Dec; 58(6):1222-7. PubMed ID: 16306197
[TBL] [Abstract][Full Text] [Related]
2. Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy.
Bekker MN; van den Akker NM; Bartelings MM; Arkesteijn JB; Fischer SG; Polman JA; Haak MC; Webb S; Poelmann RE; van Vugt JM; Gittenberger-de Groot AC
J Soc Gynecol Investig; 2006 Apr; 13(3):209-16. PubMed ID: 16638592
[TBL] [Abstract][Full Text] [Related]
3. Abnormal lymphatic development in trisomy 16 mouse embryos precedes nuchal edema.
Gittenberger-De Groot AC; Van Den Akker NM; Bartelings MM; Webb S; Van Vugt JM; Haak MC
Dev Dyn; 2004 Jun; 230(2):378-84. PubMed ID: 15162517
[TBL] [Abstract][Full Text] [Related]
4. Cardiac defects, nuchal edema and abnormal lymphatic development are not associated with morphological changes in the ductus venosus.
Burger NB; Haak MC; Kok E; de Groot CJ; Shou W; Scambler PJ; Lee Y; Cho E; Christoffels VM; Bekker MN
Early Hum Dev; 2016 Oct; 101():39-48. PubMed ID: 27405055
[TBL] [Abstract][Full Text] [Related]
5. Increased nuchal translucency is associated with jugular lymphatic distension.
Haak MC; Bartelings MM; Jackson DG; Webb S; van Vugt JM; Gittenberger-de Groot AC
Hum Reprod; 2002 Apr; 17(4):1086-92. PubMed ID: 11925410
[TBL] [Abstract][Full Text] [Related]
6. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
7. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac.
Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of the development of the ductus venosus in wild type mouse and human embryos.
Burger NB; Haak MC; De Bakker BS; Al Shaibani Z; De Groot CJ; Christoffels VM; Bekker MN
Early Hum Dev; 2013 Dec; 89(12):1067-73. PubMed ID: 23978399
[TBL] [Abstract][Full Text] [Related]
9. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema.
Bekker MN; van den Akker NM; de Mooij YM; Bartelings MM; van Vugt JM; Gittenberger-de Groot AC
Reprod Sci; 2008 Apr; 15(3):295-304. PubMed ID: 18421024
[TBL] [Abstract][Full Text] [Related]
10. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
11. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy.
Borrell A; Martinez JM; Serés A; Borobio V; Cararach V; Fortuny A
Prenat Diagn; 2003 Nov; 23(11):921-6. PubMed ID: 14634979
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Shh and FOXC2 expression correlates with aberrant lymphatic development in human fetuses with increased nuchal translucency.
de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; Wisse LJ; van Vugt JM; Gittenberger-de Groot AC
Prenat Diagn; 2009 Sep; 29(9):840-6. PubMed ID: 19548265
[TBL] [Abstract][Full Text] [Related]
13. Increased fetal nuchal translucency: possible involvement of early cardiac failure.
Montenegro N; Matias A; Areias JC; Castedo S; Barros H
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):265-8. PubMed ID: 9383878
[TBL] [Abstract][Full Text] [Related]
14. Increased nuchal translucency origins from abnormal lymphatic development and is independent of the presence of a cardiac defect.
Burger NB; Bekker MN; Kok E; De Groot CJ; Martin JF; Shou W; Scambler PJ; Lee Y; Christoffels VM; Haak MC
Prenat Diagn; 2015 Dec; 35(13):1278-86. PubMed ID: 26338284
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of hypoplastic left heart syndrome and trisomy 18 in a fetus with normal nuchal translucency and abnormal ductus venosus blood flow at 13 weeks of gestation.
Martínez Crespo JM; Del Río M; Gómez O; Borrell A; Puerto B; Cararach V; Fortuny A
Ultrasound Obstet Gynecol; 2003 May; 21(5):490-3. PubMed ID: 12768563
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of increased fetal nuchal translucency thickness.
Chen CP
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):133-8. PubMed ID: 20708516
[TBL] [Abstract][Full Text] [Related]
17. Search for hemodynamic compromise at 11-14 weeks in monochorionic twin pregnancy: is abnormal flow in the ductus venosus predictive of twin-twin transfusion syndrome?
Matias A; Ramalho C; Montenegro N
J Matern Fetal Neonatal Med; 2005 Aug; 18(2):79-86. PubMed ID: 16203591
[TBL] [Abstract][Full Text] [Related]
18. Transient increase in nuchal translucency thickness and reversed end-diastolic ductus venosus flow in a fetus with trisomy 18.
Huisman TW; Bilardo CM
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):397-9. PubMed ID: 9476323
[TBL] [Abstract][Full Text] [Related]
19. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
20. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
